The publications 'Hospital Treatment of Acute Poisoning ' and H.M. 68(92) require that all biochemical laboratories undertake certain toxicological analyses. These are-the estimation of salicylate and the identification and assay of barbiturate drugs, quantitative determination of iron in blood and stomach aspirates, of ethanol in blood, and of carbon monoxide haemoglobin, together with qualitative screening tests for the phenothiazine group of drugs.
stage is made after some form of dehydration of organic phase has been effected. Whilst traces of water can be removed by filtration through a suitable filter paper, e.g, Whatman 31, it may be necessary to treat the organic phase with solid anhydrous sodium sulphate. This procedure is not without hazard when barbiturate drugs are being sought, since traces of these drugs are absorbed onto solid sodium sulphate cakes.
Use of heparinised plasma may give over-riding peaks in the 230-250 nm area, and this could mask curves or inflexions of curves in this area of the ultraviolet spectrum. The use of serum is to be preferred.
Salicylate Apparatus

Separation of drugs by extraction methods
A good prism spectrophotometer is required which will enable measurements to be made down to 200 nm. An automatic instrument will shorten working time when numerous readings have to be made at relatively close intervals, e.g. in demonstrating the presence of barbiturates.
There should be facility for both paper and thinlayer chromatography (TLC). For TLC the small volume tanks of Eastman Kodak are invaluable since these enable rapid separations and use only 10 ml volumes of solvent systems.
Whilst the added facilities of gas chromatography, spectrofluorimetry, and infra-red spectroscopy are of great value, such instruments are unlikely to be found outside the larger laboratories. Methods involving the use of such apparatus are not included here.
Salicylic acid, its sodium salt and salicylamide all give purple colours with acid solutions of ferric salts. The other metabolites which arise after ingestion of acetylsalicylate do not react in this way.
The most commonly used reaction is that due to Trinder (1954) . Because of absorption of colour on to precipitated protein, and the production of 'impure' colours it is advisable not to report values below 5 mg/lOO ml. When testing gastric aspirate it is advantageous to adjust the reaction of the fluid to between pH 8 and 9 by cautious addition of alkali (NaOH 4 rnol/l) before adding Trinder's reagent. If this is not done it is possible to obtain negative results when relatively low concentrations of salicylate are present. The Trinder method works poorly, if at all, with autopsy material.
Salicylate behaves as a 'strong acid' and can therefore be extracted into organic solvents from weakly acid solutions. The Brodie method (Brodie Extraction of drugs using organic solvents are et al., 1944) uses ethylene dichloride as extractant generally unpopular. One of the most frequent after prior treatment with 0.6 mol/I HC\. Elution criticisms is that emulsions are formed which are thereafter is into water and the addition of ferric difficult to break by centrifugation. These may be nitrate solution (1 g/l00 ml in water) to this aqueous obviated by using larger volumes of solvent than layer yields the familiar purple colour. This method methods usually proclaim. The use of 100-250 ml is very sensitive and works well with autopsy blood. volumes and gentle, rather than vigorous, extrac-
The analgesic action of aspirin and similar tions will usually give clear-cut separations of organic preparations has been attributed to presence in the and aqueous phases.
blood of unchanged acetylsalicylate. Routh et al. Similarly, if only small volumes of serum are (1967) have described a differential spectrophotoavailable, prior dilution with three or four volumes metric absorption method for the determination of of water will prevent the formation of an un-acetylsalicylate and salicylate in the presence of one manageable mess in separating funnels.
another. Such methods can be of assistance if it is Many drug assays are enhanced if the final elution necessary to make some assessment of the time of 93 ingestion since acetylsalicylate is rarely found in appreciable quantity more than 3 h after ingestion of moderate doses. If salicylate is determined by spectrophotometric methods the biological material is extracted into ether or chloroform after adjusting the aqueous phase to about pH 3.5 (sulphuric acid diluted in water 100 ml/l). Elution is made from the organic phase into sodium hydroxide aqueous solution, 0.45 mol/I, at pH 12. Under these conditions salicylate will show maximal absorption at 300 nm, but if the concentration is greater than 15 mg/loo ml the peak may be shifted as far as 304 nm. Dilutions should be made, using the sodium hydroxide solution, until peaking occurs at 300 nm before reading from calibration curves. Salicylamide under these conditions gives a maximum at 240 nm with a secondary peak at 323 nm.
Occasionally it may be necessary to identify old or badly defaced tablets of aspirin or A.P.c. (aspirin, phenacetin, codeine) . This is most easily established using the two-plate TLC method of Liebich (1959) . Plate 1, for the demonstration of acetylsalicylate and codeine, is developed using methanol. The Rf values are respectively 0.5 and 0.65. Salicylate is located using ferric nitrate solution (2 g/loo ml) in aqueous nitric acid diluted 650 ml/l: codeine gives a brick red spot with Dragendorff's reagent." Plate 2, for phenacetin, is developed using chloroform containing 10 ml/l of ethanol. The Rf is 0.4 and the locating agent is diluted nitric acid in water 120 ml/l. When the plate is heated to between 80 and 90°C phenacetin gives a yellow spot.
In most cases of drug overdose it is difficult to predict how many tablets might have been ingested. Cumming et al. (1964) have suggested that the salicylate space in a 70 kg man is about 15 litres. Their paper also indicates a method whereby extrapolation to zero time may indicate possible posology. The MLD of salicylate is given by most authorities as 15 g for a 70 kg man, but clinical experience suggests that considerable hazard is likely when only 5 g have been ingested.
Barbiturates
The quantitative assay of barbiturate drug presents little difficulty if methods similar to that of Broughton (1956) are used.
Extractions are made from aqueous medium which has been acidified to about pH 3.5 using dilute sulphuric acid solution 100 ml/l in water.
• Dragendorff spray: (u) mix together 2g of bismuth subnitrate, 2S ml of glacial acetic acid and 100 ml of water; (b) dissolve 40 g of potassium iodide in lOa ml of water, Mix 10 ml of (u) with 10 ml of (b), 20 m1 of glacial acetic acid and 100 ml of water, Chloroform or ether may be used. Elution is made from the organic phase using sodium hydroxide solution 0.45 mol/l, pH 12. If the presence of salicylate has previously been established the organic phase must be washed with phosphate buffer 0.5 mol/I, pH 7.4 before eluting into alkali. This wash is necessary even when urine is examined since the phosphate content of urine is insufficient to wash out salicylate, which will interfere with spectrophotometry.
The alkali fraction at pH 12 will exhibit maximal absorption near to 255 nm. If the pH is changed by the addition of borate buffer 0.6 rnol/l or aqueous ammonium chloride solution 16 g/IOO ml, to pH 10, the maximum is shifted to 240 nm. Isosbestic points will therefore occur at 230 ± 3 nm and 248 ± 3 nm.
Low concentrations of barbiturate will tend to bring these isosbestic points closer, and at a level of 0.5 mg/IOO ml these points may lie as close as 235 and 245 nm. At even lower concentrations the curves may only graze one another. The probable lower limit of sensitivity of such methods is around 0.3 mg/100 ml. Such values should only be reported if there is corroborative evidence, e.g. gas chromatography or TLC.
Other drugs may interfere in the spectrophotometry of the pH 12 fraction. Thus a-phenyl a-ethyl glutarimide (Glutethimide: Doriden (R» shows a maximal absorption at 235 nm, but rapid hydrolysis occurs at room temperature, and this deletion can be made a basis for quantitative measurement of this drug. ,a-ethyl ,a-methyl glutarimide (Megimide (R» gives a maximum at 230 nm but this is hydrolysed much more slowly under the same conditions. When the pH of the solution is changed to pH 10 the interference due to the glutarimides is deleted. The barbiturate spectrum itself is deleted by the addition of a solution of sulphuric acid in water (500 rnl/l) to a pH 2. This is a useful confirmatory test. At 240 nm LlE~~I~~1.0 for a barbiturate concentration of about 2.25 mg/loo ml.
If a patient is on continued therapy using phenobarbitone a barbiturate level up to 3 mg/IOOml may be obtained. A sedating dose of amylobarbitone may give day-to-day levels around 0.5 mg/l 00 ml. A level of 1.5 mg/loo ml of amylobarbitone will often be associated with an unconscious state in a patient, for phenobarbitone the level may well be in excess of 8 mg/loo ml. It is therefore important to identify the barbiturate as well as determining the blood level.
Partial identification of the barbiturates into groups may be made by immersing the alkaline solutions in a boiling water bath for 30 min. and measuring the degree of hydrolysis by comparing extinctions before and after boiling. Under these conditions the shorter acting barbiturates are only 10% hydrolysed, whilst the longer acting members (e.g. phenobarbitone) may be 50% hydrolysed. Such an approach is not considered positive identification.
Thin layer chromatography affords a rapid means of identification and is performed using a concentrate of the organic extract. The Eastman Kodak tanks use small sheets of silica gel (50 x 100 mm), and single ascending runs using chloroform/acetone 9: 1 will yield separations in 10-12 min. If there is insufficient resolution in this time the sheet is air dried and re-run to obtain more clear-cut separations. Solutions of various barbiturates at a concentration of 1 mg/ml in chloroform are used as standards. Rf values need to be established every day since small changes in ambient conditions may give varying values. The locating agents are aqueous potassium perrnanganate solution (100 mg/loo ml) and diphenylcarbazone in chloroform (DPC: 10 mg/loo rnl). The permanganate spray gives yellow spots on a purple background and reacts only with barbiturates having an unsaturated side-chain or 2-mercapto substituent. DPC yields violet spots with saturated and blue spots with unsaturated compounds. An alternative spray is Zwikker's reagent (40 ml of 10 g/I copper sulphate in water mixed with 10 ml of pyridine, water being added to the mixture to a final volume of 100 ml), This gives pink spots on a blue background.
Paper chromatography generally takes much longer, although the reversed phase chromatographic procedure of Street can give results in about 20-25 min.
The colour reaction with DPC and similar substances has been made the basis of a number of methods for colorimetric assay of barbiturates. These methods are not as specific as may have been claimed. Sera which contain no barbiturate but do contain other drugs including phenothiazines and their metabolites may occasionally give false positive reactions. Many sera appear to contain unknown natural substances, not in themselves drugs, which also interfere with the reaction. Imperfectly clean reaction tubes can give false positive reactions and although these are minimised using chemically clean glassware there remain some unexplained false positive results. Finally it must be allowed that some barbiturates fail to react with DPC and kindred substances.
Iron
Most overdoses arise from the ingestion of tablets containing ferrous salts.
Qualitative tests for the presence of iron may be performed on as little as two drops of gastric aspirate.
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Acidification with a drop of dilute hydrochloric acid followed by addition of a few drops of aqueous solutions (1 g/100 ml) of potassium ferricyanide or ferrocyanide will give blue colours or blue precipitates.
Quantitative analysis in serum or gastric aspirate is easily performed using methods currently in use, e.g, the Ramsay (1957) method. Where it may be inconvenient to prepare fresh solutions each day a one-off assay may effectively be performed using one of the currently offered kit methods.
Assay of iron in urine should rarely be required. It is not easy to obtain satisfactory results particularly if a chelating agent has been used therapeutically. Atomic absorption spectrophotometry is probably the method of choice, but many instruments are insufficiently sensitive for direct assay from biological material.
Ethanol
The determination of ethanol is best performed by gas chromatographic procedures. Commercial kits employing the dehydrogenase reaction are available and will give valid one-off results.
A freshly passed urine sample treated with an equal part of 10 g/l00 ml sodium dichromate in sulphuric acid solution (500 ml concentrated acid diluted to 1 I with water) yields a green colour in the cold in 10-15 sec. when ethanol is present at a concentration greater than 150 mg/l00 mI. Slower reaction times are obtained with lower concentrations of ethanol. It is important to exclude the presence of ketone bodies before doing this test.
Carbon monoxide in blood (COHb)
Rapid qualitative tests are unreliable unless there is a high concentration in the blood.
One drop of suspected blood when diluted to 15 ml with water will give a pink solution if more than 50 % of carbon monoxide haemoglobin is present. If this test is performed in parallel with normal and 100% saturated COHb blood, and to each tube is added a few drops of 25 g/l00 ml sodium hydroxide solution with rapid mixing, colour changes occur. Normal blood becomes strawcoloured, the positive control will turn cherry-redpersisting for about 60 sec., and intermediate time persistence of the cherry-red colour will be a rough measure of the degree of COHb saturation. This test is specific and sensitive for concentrations greater than 20% COHb.
In the above, as in similar tests, it is preferable to prepare saturated solutions using pure carbon monoxide gas, e.g, by the action of concentrated sulphuric acid on formic acid, rather than to use town-gas supplies. It takes at least 15 min. to achieve 100% saturation of normal blood with carbon monoxide. It is difficult to prepare intermediate solutions between 0 and 100 % saturation since saturated solutions always contain an unknown quantity of CO in solution which will readily combine with the fresh blood diluent used, hence unpredictable concentrations are obtained.
For clinical chemistry laboratories the method of Whitehead and Worthington (1961) is recommended. Diffusion tests, although sensitive and specific offer little additional accuracy and need experience. Determination of carbon monoxide in air samples or flue gases require a more sophisticated approach which is beyond the resources of most laboratories.
Phenothiazines
Demonstration of this group of drugs is most easily effected using freshly voided urine samples.
To I ml of urine is added an equal volume of FPN reagent. A variety of colours result from amberyellow, through pink and red, to metallic blue. FPN reagent consists of: aq. Ferric chloride 5 g/100 mJ 5 parts (F) aq. Perchloric acid 200 ml/I 45 parts (P) aq. Nitric acid 500 ml/l 50 parts (N) It appears to be stable indefinitely. Compounds giving a pink colour include prochlorperazine, thiopropazate, pipamazine, promazine, chlorpromazine, mepazine and perphenazine. An amber-yellow colour is given by fluphenazine and trifluoperazine. Thioridazine gives a blue colour.
Metabolites ofphenothiazines often confer reddish and amber colours on the aqueous phase when fractionating weak acids, e.g. in the barbiturate methods.
The presence of imipramine, desipramine and trimipramine may be demonstrated in urine using the Forrest reagent for the same experimental conditions described above. A green colour is obtained. Forrest reagent (Forrest et aI., 1961) consists of equal parts of the following aqueous solutions:
aq. potassium dichromate 0.2 g/l00 ml aq. sulphuric acid 300 rnl/l aq. perchloric acid 200 ml/l aq. nitric acid 500 ml/l The most commonly used chromatographic methods used are the elegant sulphoxide derivative method of Kofoed et al. (1966) , or TLC on silica gel using methanol/ammonia (0.88) 100:1.5. The locating reagent is the FPN reagent. Alcoholic solutions of the individual drugs should be used for comparative Rf values.
Amphetamines
Many laboratories are now being asked to screen urine samples for the presence of amphetamine drugs. This is by no means simple unless heavy doses have been ingested. Under these circumstances extraction from fresh urine, made alkaline to pH 11 by addition of 4 mol/l NaOH into chloroform followed by elution into 0.1 rnol/l sulphuric acid may give an easily identifiable ultra-violet spectrum (Em"" 257 nm with subsidiary peaks at 252 and 264 nm). Native methylamphetamine gives an identical curve. Distillation methods followed by extraction procedures often give disappointing results.
Dye conjugation tests are not specific, positive results being given by a wide range of basic drugs, an avowed technique which takes no account of this fact should be practised only with great caution.
Where a positive result has been obtained it should always be confirmed by TLC. A useful solvent system is butanol/acetic acid/water 5: 1:4 using silica gel plates or sheets. The simplest locating reagent is probably bromocresol green 0.5 gjlOO ml in ethanol (lower concentrations down to 0.1 gjl 00 ml may be used according to individual experience or choice). This gives blue spots on a white background after drying out at room temperature.
Although it is commonly held that amphetamine drugs may be identified up to 72 h after ingestion the only reliable method of establishing presence of this group of drugs is by gas chromatography.
Methaqualone
The increasing use of Mandrax (R) therapeutically and for other reasons may lead to a request for identification and assay of methaqualone. It separates mainly in the basic fraction but also appears in smaller amounts in both neutral and weak acid fractions in the general scheme of analysis.
The method of Lawson and Brown (1967) is adequate for clinical purposes, although this does not underline the necessity for operating at an alkaline pH. Briefly the method consists of taking an aliquot of fluid (3 ml) and making this alkaline to pH 9 using NaOH 2 mol/l, Extraction into about 15 ml of ether and rejection of the aqueous layer is followed by a phosphate wash (0.5 rnol/l buffer pH 7). The aqueous layer is again discarded and the etheral layer is treated with about 0.5 g of solid anhydrous sodium sulphate followed by filtration. The ether is then gently evaporated and the residue, which has a distinctive odour, is dissolved in 3 ml R.R. ethanol. The ultra-violet spectrum is evolved against a blank of R.R. ethanol. Characteristic peaks occur at 315, 305, 295, and 265 nm. It is advisable to run a parallel blank using normal serum and to subtract the extinction at 265 nm from that of the drug containing sample at this wavelength. The result is read from a calibration curve. An idea of the format of the ultra-violet spectrum can be obtained by performing the technique on a ground-up tablet, but calibration curves must be prepared using the pure drug. The whole technique may be conveniently carried out using Universal containers for the extraction and washing procedure, and a thin-walled boiling tube for the evaporation of the ether phase.
Genera! comments
Bulk prescribing habits and the tendency of most people to hoard tablets have led to increasing numbers of patients being admitted to hospital suffering from polypharmaceutical overdoses. Abuse of drugs by certain sections of the public has further increased the analytical problems which may arise. Any clinical chemistry department may therefore be assailed for analyses which lie far outside normal capacity and it cannot be emphasised too strongly that such problems may lead the analyst into deep waters. Spot tests are, for the most part, extremely misleading. Unequivocal identification requires sophisticated instrumentation not only in the field of drug assay but in the kindred field of trace metal analysis. It seems certain that it will become necessary to establish reference laboratories in the various Regions of the N.H.S. to deal with these difficult problems of analysis.
Even so clinicians continue to think that testing for the presence of drugs is a simple matter of adding one reagent to the sample and immediately obtaining evidence not only of identity, but also of concentration of any of the approximately 6,000 drugs in current therapeutic use. This is perhaps particularly true for the drugs of addiction. It is therefore worth observing that heroin (diamorphine) is very rapidly hydrolysed after introduction into the body and cannot be identified as heroin. The identification of morphine requires care and one should not allow the results of rapid tests to be taken as positive evidence of its presence. Lysergic acid diethylamide (LSD) has never been satisfactorily demonstrated in blood or urine even in samples taken at timed intervals after deliberate dosage. The identification of the native material is comparatively easy if a fluorimeter is available but should not be undertaken for legal reasons, by a clinical chemist. Similarly the identification or even handling of suspected cannabis resin should be avoided. Both these identifications are matters which must be referred to forensic laboratories by police authorities.
The clinical chemist who is interested in toxicological work is well advised to acquaint himself with the appropriate regulations of the Acts relating to Dangerous Drugs. Any persons receiving samples of these drugs for identification purposes lay themselves open to the possibility of being described as 'an unauthorised person in possession', and it may be by no means easy to convince others that 'it was necessary in the interest of the patient and his clinical care'.
